Violation Tracker Individual Record

Company: 
Novo Nordisk Inc.
Current Parent Company: 
Novo Holdings A/S
Penalty: 
$1,100,000
Year: 
2017
Date: 
September 5, 2017
Offense Group: 
healthcare-related offenses
Primary Offense: 
off-label or unapproved promotion of medical products
Secondary Offense: 
drug or medical equipment safety violation
Violation Description: 

The California Insurance Commissioner reached a $1.1 million settlement with pharmaceutical company Novo Nordisk Inc. over allegations that Novo Nordisk's drug Victoza was extensively promoted for uses not approved of by the Food and Drug Administration, a violation of the Insurance Frauds Prevention Action.

Level of Government: 
state
Action Type: 
agency action
Agency: 
California Department of Insurance
Civil or Criminal Case: 
civil
Facility State: 
California
HQ Country of Parent: 
Denmark
Ownership Structure of Parent: 
privately held
Major Industry of Parent: 
pharmaceuticals
Specific Industry of Parent: 
pharmaceuticals
Source Notes: 
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note: 
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.